American Seed & Oil Company CEO Discusses Current Medical Marijuana and Hemp Cultivation In Online Interview
DALLAS, Dec 30, 2014 / -- Algae International Group, Inc. (OTC: ALGA), through its operating subsidiary American Seed & Oil Company, Inc., announced an online interview with CEO Steven Rash regarding current and future hemp operations.
- Largest legal hemp harvest in Vermont in 60 years
- Plans to begin hemp production in New York in 2015
- Pending pilot research agreement with NY based university
- EpiVape preparing for launch in phased campaign
- CBD Hemp oil research for treatment of neurological disorders
- 1000 acres commitment from Vermont farmers for Hemp production
Mr. Steven Rash, the CEO of Algae International Group, Inc. discusses the Company’s current hemp and medical marijuana cultivation operations, plans for development of the EpiVape device, and expansion into new areas of hemp production for 2015.
A link to the online audio interview Mr. Steven Rash can be found by going to http://www.wallstreetnewscast.com/profile/alga.html
About Algae International Group, Inc.
Algae International Group, Inc. (OTC: ALGA), through its operating subsidiary American Seed & Oil Company, Inc., is in the business of hemp production in Vermont to supply seed to the expanding hemp farming market, hemp based consumer products market, and hemp based construction material market. The Company is also piloting a number of other cannabis related products. For more information please visit www.americanseedandoil.com
Follow the company on Twitter: http://twitter.com/US_HEMP
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.